194 related articles for article (PubMed ID: 34172992)
21. Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.
Tan S; Zhao J; Sun Z; Cao S; Niu K; Zhong Y; Wang H; Shi L; Pan H; Hu J; Qian L; Liu N; Yuan J
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14231-14242. PubMed ID: 32513687
[TBL] [Abstract][Full Text] [Related]
22. Murine model of genetic demyelinating disease: the twitcher mouse.
Suzuki K; Taniike M
Microsc Res Tech; 1995 Oct; 32(3):204-14. PubMed ID: 8527855
[TBL] [Abstract][Full Text] [Related]
23. NEK1-mediated retromer trafficking promotes blood-brain barrier integrity by regulating glucose metabolism and RIPK1 activation.
Wang H; Qi W; Zou C; Xie Z; Zhang M; Naito MG; Mifflin L; Liu Z; Najafov A; Pan H; Shan B; Li Y; Zhu ZJ; Yuan J
Nat Commun; 2021 Aug; 12(1):4826. PubMed ID: 34376696
[TBL] [Abstract][Full Text] [Related]
24. Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease.
Giacomini A; Ackermann M; Belleri M; Coltrini D; Nico B; Ribatti D; Konerding MA; Presta M; Righi M
Angiogenesis; 2015 Oct; 18(4):499-510. PubMed ID: 26310512
[TBL] [Abstract][Full Text] [Related]
25. K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo.
Shutinoski B; Alturki NA; Rijal D; Bertin J; Gough PJ; Schlossmacher MG; Sad S
Cell Death Differ; 2016 Oct; 23(10):1628-37. PubMed ID: 27258786
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy.
Belleri M; Ronca R; Coltrini D; Nico B; Ribatti D; Poliani PL; Giacomini A; Alessi P; Marchesini S; Santos MB; Bongarzone ER; Presta M
Brain; 2013 Sep; 136(Pt 9):2859-75. PubMed ID: 23983033
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of microglial receptor-interacting protein kinase 1 ameliorates neuroinflammation following cerebral ischaemic stroke.
Jiao Y; Wang J; Zhang H; Cao Y; Qu Y; Huang S; Kong X; Song C; Li J; Li Q; Ma H; Lu X; Wang L
J Cell Mol Med; 2020 Nov; 24(21):12585-12598. PubMed ID: 32990414
[TBL] [Abstract][Full Text] [Related]
28. Characterization of adipose-derived stromal/stem cells from the Twitcher mouse model of Krabbe disease.
Zhang X; Semon JA; Zhang S; Strong AL; Scruggs BA; Gimble JM; Bunnell BA
BMC Cell Biol; 2013 Apr; 14():20. PubMed ID: 23590629
[TBL] [Abstract][Full Text] [Related]
29. [Krabbe disease (globoid cell leukodystrophy)].
Sakai N; Inui K; Okada S
Nihon Rinsho; 1995 Dec; 53(12):2947-51. PubMed ID: 8577041
[TBL] [Abstract][Full Text] [Related]
30. Binding of RAGE and RIPK1 induces cognitive deficits in chronic hyperglycemia-derived neuroinflammation.
Zhou X; Zhu Y; Gao L; Li Y; Li H; Huang C; Liu Y; Hu A; Ying C; Song Y
CNS Neurosci Ther; 2024 Mar; 30(3):e14449. PubMed ID: 37665158
[TBL] [Abstract][Full Text] [Related]
31. RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis.
Saito N; Honma M; Shibuya T; Iinuma S; Igawa S; Kishibe M; Ishida-Yamamoto A
J Dermatol Sci; 2018 Jul; 91(1):79-86. PubMed ID: 29661487
[TBL] [Abstract][Full Text] [Related]
32. Genetic background markedly influences vulnerability of the hippocampal neuronal organization in the "twitcher" mouse model of globoid cell leukodystrophy.
Tominaga K; Matsuda J; Kido M; Naito E; Yokota I; Toida K; Ishimura K; Suzuki K; Kuroda Y
J Neurosci Res; 2004 Aug; 77(4):507-16. PubMed ID: 15264220
[TBL] [Abstract][Full Text] [Related]
33.
Karunakaran D; Nguyen MA; Geoffrion M; Vreeken D; Lister Z; Cheng HS; Otte N; Essebier P; Wyatt H; Kandiah JW; Jung R; Alenghat FJ; Mompeon A; Lee R; Pan C; Gordon E; Rasheed A; Lusis AJ; Liu P; Matic LP; Hedin U; Fish JE; Guo L; Kolodgie F; Virmani R; van Gils JM; Rayner KJ
Circulation; 2021 Jan; 143(2):163-177. PubMed ID: 33222501
[TBL] [Abstract][Full Text] [Related]
34. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis.
Takahashi N; Vereecke L; Bertrand MJ; Duprez L; Berger SB; Divert T; Gonçalves A; Sze M; Gilbert B; Kourula S; Goossens V; Lefebvre S; Günther C; Becker C; Bertin J; Gough PJ; Declercq W; van Loo G; Vandenabeele P
Nature; 2014 Sep; 513(7516):95-9. PubMed ID: 25186904
[TBL] [Abstract][Full Text] [Related]
35. Experimental therapies in the murine model of globoid cell leukodystrophy.
Li Y; Sands MS
Pediatr Neurol; 2014 Nov; 51(5):600-6. PubMed ID: 25240259
[TBL] [Abstract][Full Text] [Related]
36. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
[TBL] [Abstract][Full Text] [Related]
37. Krabbe disease: an overview.
Pastores GM
Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S75-81. PubMed ID: 20040316
[TBL] [Abstract][Full Text] [Related]
38. History, genetic, and recent advances on Krabbe disease.
Graziano AC; Cardile V
Gene; 2015 Jan; 555(1):2-13. PubMed ID: 25260228
[TBL] [Abstract][Full Text] [Related]
39. The twitcher mouse: a model for Krabbe disease and for experimental therapies.
Suzuki K; Suzuki K
Brain Pathol; 1995 Jul; 5(3):249-58. PubMed ID: 8520724
[TBL] [Abstract][Full Text] [Related]
40. Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease).
Luzi P; Rafi MA; Zaka M; Curtis M; Vanier MT; Wenger DA
Mol Genet Metab; 2001 Jul; 73(3):211-23. PubMed ID: 11461188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
